pharmaceuticals-and-healthcare

EMEA (Europe, Middle East and Africa) Bio-pharma Market Report 2017


Published On : May 2017

Category : Pharmaceutical

No. of Pages : 110 pages

  • $4000
  • $8000

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  
Table of Contents

EMEA (Europe, Middle East and Africa) Bio-pharma Market Report 2017
1 Bio-pharma Overview
1.1 Product Overview and Scope of Bio-pharma
1.2 Classification of Bio-pharma
1.2.1 EMEA Bio-pharma Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Bio-pharma Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Monoclonal Antibodies
1.2.4 Recombinant Proteins
1.2.5 Granulocyte-Colony Stimulating Factor (G-CSF)
1.2.6 Interferons
1.2.7 Recombinant Human Insulin
1.2.8 Erythropoietin
1.2.9 Vaccines
1.2.10 Growth Hormones
1.2.11 Purified Proteins
1.2.12 Others
1.3 EMEA Bio-pharma Market by Application/End Users
1.3.1 EMEA Bio-pharma Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Metabolic Disorders
1.3.3 Oncology
1.3.4 Neurological Disorders
1.3.5 Cardiovascular Diseases
1.3.6 Inflammatory and Infectious Diseases
1.3.7 Others
1.4 EMEA Bio-pharma Market by Region
1.4.1 EMEA Bio-pharma Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Bio-pharma (2012-2022)
1.5.1 EMEA Bio-pharma Sales and Growth Rate (2012-2022)
1.5.2 EMEA Bio-pharma Revenue and Growth Rate (2012-2022)

2 EMEA Bio-pharma Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Bio-pharma Market Competition by Players/Manufacturers
2.1.1 EMEA Bio-pharma Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Bio-pharma Revenue and Share by Players (2012-2017)
2.1.3 EMEA Bio-pharma Sale Price by Players (2012-2017)
2.2 EMEA Bio-pharma (Volume and Value) by Type/Product Category
2.2.1 EMEA Bio-pharma Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Bio-pharma Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Bio-pharma Sale Price by Type (2012-2017)
2.3 EMEA Bio-pharma (Volume) by Application
2.4 EMEA Bio-pharma (Volume and Value) by Region
2.4.1 EMEA Bio-pharma Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Bio-pharma Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Bio-pharma Sales Price by Region (2012-2017)

3 Europe Bio-pharma (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Bio-pharma Sales and Value (2012-2017)
3.1.1 Europe Bio-pharma Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Bio-pharma Revenue and Growth Rate (2012-2017)
3.2 Europe Bio-pharma Sales and Market Share by Type
3.3 Europe Bio-pharma Sales and Market Share by Application
3.4 Europe Bio-pharma Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Bio-pharma Sales Volume by Countries (2012-2017)
3.4.2 Europe Bio-pharma Revenue by Countries (2012-2017)
3.4.3 Germany Bio-pharma Sales and Growth Rate (2012-2017)
3.4.4 France Bio-pharma Sales and Growth Rate (2012-2017)
3.4.5 UK Bio-pharma Sales and Growth Rate (2012-2017)
3.4.6 Russia Bio-pharma Sales and Growth Rate (2012-2017)
3.4.7 Italy Bio-pharma Sales and Growth Rate (2012-2017)
3.4.8 Benelux Bio-pharma Sales and Growth Rate (2012-2017)

4 Middle East Bio-pharma (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Bio-pharma Sales and Value (2012-2017)
4.1.1 Middle East Bio-pharma Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Bio-pharma Revenue and Growth Rate (2012-2017)
4.2 Middle East Bio-pharma Sales and Market Share by Type
4.3 Middle East Bio-pharma Sales and Market Share by Application
4.4 Middle East Bio-pharma Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Bio-pharma Sales Volume by Countries (2012-2017)
4.4.2 Middle East Bio-pharma Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Bio-pharma Sales and Growth Rate (2012-2017)
4.4.4 Israel Bio-pharma Sales and Growth Rate (2012-2017)
4.4.5 UAE Bio-pharma Sales and Growth Rate (2012-2017)
4.4.6 Iran Bio-pharma Sales and Growth Rate (2012-2017)

5 Africa Bio-pharma (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Bio-pharma Sales and Value (2012-2017)
5.1.1 Africa Bio-pharma Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Bio-pharma Revenue and Growth Rate (2012-2017)
5.2 Africa Bio-pharma Sales and Market Share by Type
5.3 Africa Bio-pharma Sales and Market Share by Application
5.4 Africa Bio-pharma Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Bio-pharma Sales Volume by Countries (2012-2017)
5.4.2 Africa Bio-pharma Revenue by Countries (2012-2017)
5.4.3 South Africa Bio-pharma Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Bio-pharma Sales and Growth Rate (2012-2017)
5.4.5 Egypt Bio-pharma Sales and Growth Rate (2012-2017)
5.4.6 Algeria Bio-pharma Sales and Growth Rate (2012-2017)

6 EMEA Bio-pharma Manufacturers/Players Profiles and Sales Data
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Bio-pharma Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 F. Hoffmann-La Roche AG
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Bio-pharma Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 F. Hoffmann-La Roche AG Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Johnson & Johnson Services
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Bio-pharma Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Johnson & Johnson Services Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Sanofi, Amgen
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Bio-pharma Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Sanofi, Amgen Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 AbbVie
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Bio-pharma Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 AbbVie Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Merck & Co., Inc
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Bio-pharma Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Merck & Co., Inc Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Biogen Idec
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Bio-pharma Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Biogen Idec Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Bayer AG
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Bio-pharma Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Bayer AG Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Eli Lilly and Company
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Bio-pharma Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Eli Lilly and Company Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Novartis AG GlaxoSmithKline Plc
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Bio-pharma Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Bristol-Myers Squibb Company
6.12 AstraZeneca PLC
6.13 Abbott Laboratories

7 Bio-pharma Manufacturing Cost Analysis
7.1 Bio-pharma Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Bio-pharma

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Bio-pharma Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Bio-pharma Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Bio-pharma Market Forecast (2017-2022)
11.1 EMEA Bio-pharma Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Bio-pharma Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Bio-pharma Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Bio-pharma Price and Trend Forecast (2017-2022)
11.2 EMEA Bio-pharma Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Bio-pharma Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Bio-pharma Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Bio-pharma Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Bio-pharma Sales Forecast by Type (2017-2022)
11.7 EMEA Bio-pharma Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


Back To Top